What is the official website of Sandoz Österreich ?

The official website of Sandoz Österreich is https://www.sandoz.at/.

What is Sandoz Österreich's cybersecurity risk score?

Sandoz Österreich has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sandoz Österreich experienced?

According to Rankiteo, Sandoz Österreich currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sandoz Österreich been affected by any supply chain cyber incidents ?

According to Rankiteo, Sandoz Österreich has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sandoz Österreich have SOC 2 Type 1 certification ?

According to Rankiteo, Sandoz Österreich is not certified under SOC 2 Type 1.

Does Sandoz Österreich have SOC 2 Type 2 certification ?

According to Rankiteo, Sandoz Österreich does not hold a SOC 2 Type 2 certification.

Does Sandoz Österreich comply with GDPR ?

According to Rankiteo, Sandoz Österreich is not listed as GDPR compliant.

Does Sandoz Österreich have PCI DSS certification ?

According to Rankiteo, Sandoz Österreich does not currently maintain PCI DSS compliance.

Does Sandoz Österreich comply with HIPAA ?

According to Rankiteo, Sandoz Österreich is not compliant with HIPAA regulations.

Does Sandoz Österreich have ISO 27001 certification ?

According to Rankiteo,Sandoz Österreich is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sandoz Österreich operate in ?

Sandoz Österreich operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sandoz Österreich have ?

Sandoz Österreich employs approximately 189 people worldwide.

Does Sandoz Österreich own any subsidiaries ?

Sandoz Österreich presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sandoz Österreich have ?

Sandoz Österreich's official LinkedIn profile has approximately 8,025 followers.

What is the NAICS classification code for Sandoz Österreich ?

Sandoz Österreich is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sandoz Österreich have a Crunchbase profile ?

No, Sandoz Österreich does not have a profile on Crunchbase.

Does Sandoz Österreich have a LinkedIn profile ?

Yes, Sandoz Österreich maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sandoz-austria.

How many cybersecurity incidents has Sandoz Österreich experienced ?

As of June 8, 2026, Rankiteo reports that Sandoz Österreich has not experienced any cybersecurity incidents.

How many peer or competitor companies does Sandoz Österreich have ?

Sandoz Österreich has an estimated 5,674 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Sandoz Österreich

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Sandoz Österreich Vendor Cyber Rating & Cyber Score

sandoz.at

Add Your Compliance Badge

💙Bei Sandoz haben wir ein klares Ziel: der Welt Zugang zu lebensrettenden Medikamenten zu geben - und das seit über 77 Jahren in Österreich. 💊Die Entdeckung von Penicillin hat die Medizin revolutioniert. Unser österreichisches Werk, im Herzen Tirols, hat schon in der Nachkriegszeit mit der Penicillin-Produktion begonnen. Hier gelang es auch erstmals, Penicillin in Tablettenform herzustellen. Eine medizinische Sensation. 🏭Damals wurde eine stillgelegte Brauerei in eine biochemische Fabrik umgewidmet. Heute produziert das Werk über 4000 Tonnen an Wirkstoffen im Jahr. 🏰Voller Pioniergeist stellen wir die letzte große Penicillin-Hochburg der westlichen Welt – vom Wirkstoff bis zur Tablette wird in Kundl Antibiotika für den ganzen

Sandoz Österreich A.I CyberSecurity Scoring

Scoring History

Sandoz Österreich

Sandoz Österreich CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Sandoz Österreich Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Sandoz Österreich

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Österreich in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sandoz Österreich in 2026.

Incident Types Sandoz Österreich vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Österreich in 2026.

Incident History - Sandoz Österreich (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sandoz Österreich Subsidiaries

Sandoz Österreich

Pharmaceutical Manufacturing

Website: https://www.sandoz.at/

Company Size: 1,001-5,000 employees

SandozPharmaceutical Manufacturing

Sandoz do BrasilFabricação de produtos farmoquímicos e farmacêuticos

Sandoz EgyptPharmaceutical Manufacturing

Sandoz ItaliaPharmaceutical Manufacturing

Sandoz MéxicoPharmaceutical Manufacturing

Sandoz CanadaPharmaceutical Manufacturing

Sandoz IberiaPharmaceutical Manufacturing

Sandoz FrancePharmaceutical Manufacturing

Sandoz PolskaPharmaceutical Manufacturing

Sandoz Czech RepublicPharmaceutical Manufacturing

Sandoz India Pvt LtdPharmaceutical Manufacturing

Sandoz HrvatskaPharmaceutical Manufacturing

Sandoz SrbijaPharmaceutical Manufacturing

Sandoz UK & IrelandPharmaceutical Manufacturing

Sandoz Australia & New ZealandPharmaceutical Manufacturing

Sandoz NederlandPharmaceutical Manufacturing

Sandoz HungáriaPharmaceutical Manufacturing

Lek PharmaceuticalsPharmaceutical Manufacturing

Sandoz SverigePharmaceutical Manufacturing

Sandoz DanmarkPharmaceutical Manufacturing

Sandoz RomaniaPharmaceutical Manufacturing

Loading…

Sandoz Österreich Similar Companies

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Loading…

NEWS

Sandoz Österreich CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

April 02, 2024 07:00 AM

Sandoz Antibiotic Manufacturing Facility, Kundl, Austria

Sandoz, a generic pharmaceuticals company based in Switzerland, opened an antibiotic manufacturing facility in Kundl, Austria, in November 2023.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-11466

SUMMARY

A weakness has been identified in zilliztech deep-searcher up to 0.0.2. This affects the function CollectionRouter.invoke of the file deepsearcher/agent/collection_router.py. This manipulation of the argument kwargs causes improper access controls. Remote exploitation of the attack is possible. The exploit has been made available to the public and could be used for attacks. The pull request to fix this issue awaits acceptance.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 5.4)

cvss2

Base Score: 5.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:N/A:P

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-11465

SUMMARY

A security flaw has been discovered in songquanpeng one-api up to 0.6.11-preview.7. Affected by this issue is the function Redeem of the file model/redemption.go of the component Redemption Code Top-Up Endpoint. The manipulation results in business logic errors. The attack may be launched remotely. The attack requires a high level of complexity. The exploitation is known to be difficult. The exploit has been released to the public and may be used for attacks. The pull request to fix this issue awaits acceptance.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 3.1)

cvss2

Base Score: 2.1

Complexity: HIGH

AV:N/AC:H/Au:S/C:N/I:P/A:N

cvss3

Base Score: 3.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:N/I:L/A:N

cvss4

Base Score: 1.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

1.6

REFERENCES

CVE-2026-11464

SUMMARY

A vulnerability was identified in JeecgBoot up to 3.9.2. Affected by this vulnerability is the function queryPageList of the file src\main\java\org\jeecg\modules\system\controller\SysUserController.java of the component User List Endpoint. The manipulation of the argument salt leads to information disclosure. The attack may be initiated remotely. The attack is considered to have high complexity. The exploitation appears to be difficult. The exploit is publicly available and might be used. A fix is planned for the upcoming release.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 3.1)

cvss2

Base Score: 2.1

Complexity: HIGH

AV:N/AC:H/Au:S/C:P/I:N/A:N

cvss3

Base Score: 3.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 1.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

1.6

REFERENCES

CVE-2026-11463

SUMMARY

A vulnerability was determined in USCiLab Cereal up to 1.3.2. Affected is an unknown function of the component Shared Pointer Handler. Executing a manipulation can lead to type confusion. The attack can be launched remotely. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-11462

SUMMARY

A vulnerability was found in Chengdu Everbrite Network Technology BeikeShop up to 1.6.0.22. This impacts the function callback of the file plugins/Stripe/Controllers/StripeController.php of the component Stripe Plugin. Performing a manipulation of the argument Request results in improper authorization. The attack can be initiated remotely. The exploit has been made public and could be used. The patch is named 6719e0fc690ea0a998452092862e0f0a17c65968. It is suggested to install a patch to address this issue.

Published

Date2026-06-07

Updated

Date2026-06-07

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…